| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |